You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTCT Sale Disclosure
Boulding Mark Elliott · SEC Form 4 · Filed Jun 22, 2026
Sale
Calculated transaction value
$146.59K
Boulding Mark Elliott Exec. VP And CLO
PTCT
PTC Therapeutics
PTCT
Transaction date
Jun 17, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 5 days later
PTCT daily price context
Close on/before transaction
$78.53
Jun 17, 2026
First close after public filing
$82.13
Jun 23, 2026
30-day return after filing
-4.54%
Through Jul 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,850 shares @ $79.24
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001578852-26-000018
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.31M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Exercise | Jun 17, 2026 | $396.06K |
| Ptc Therapeutics, Inc. PTCT | Sale | Jun 17, 2026 | $518.1K |
| Ptc Therapeutics, Inc. PTCT Current | Sale | Jun 17, 2026 | $146.59K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jun 17, 2026 | $93.64K |
| Ptc Therapeutics, Inc. PTCT | Sale | Jun 17, 2026 | $133.69K |
| Ptc Therapeutics, Inc. PTCT | Sale | Jun 17, 2026 | $24.49K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jun 17, 2026 | $0 |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jun 17, 2026 | $0 |